Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

NCT06952517 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Papular-pustular Rosacea
Papulopustular Rosacea (PPR)
Papulopustular Rosacea

Interventions

DRUG: Clascoterone Cream 1%

Sponsor

Narrows Institute for Biomedical Research

Collaborators

[object Object]